Satsuma Pharmaceuticals Inc expected to post a loss of 42  cents a share - Earnings Preview

Satsuma Pharmaceuticals

07/05/2021 14:37

* Satsuma Pharmaceuticals Inc  STSA.OQ   STSA.O  is expected
to show a no change in quarterly revenue when it reports
results on May 10 (estimated) .
​* Refinitiv's mean analyst estimate for Satsuma Pharmaceuticals
Inc is for a loss of 42 cents per share. For the same quarter
last year, the company reported a loss of 68 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts had fallen by
about 17.1% in the last three months. ​
* Wall Street's median 12-month price target for Satsuma
Pharmaceuticals Inc is $7​, about 29.6% above​ its last closing
price of $4.93. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.65       -0.53      -0.72     Missed  -36.2
 Sep. 30 2020  -0.75       -0.69      -0.69     Met     0.7
 Jun. 30 2020  -0.71       -0.71      -0.65     Beat    8.9​
 Mar. 31 2020  -0.67       -0.67      -0.68     Missed  -1.5
 Dec.          -0.80​      -0.80      -0.62     Beat    23​
 31​ 2019​                                              
 Sep. 30 2019  -1.01       -1.01      -2.26     Missed  -123.8
                                                        ​
 This summary was machine generated May 7 at 13:37 GMT.  All
figures in US dollars unless otherwise stated